Investigator | Year of publication | Patients (n) | Median Follow-up (months) | Freedom from Biochemical Relapse |
---|---|---|---|---|
Anscher [11] | 2000 | 89 | 48 | 50% at 4 years |
Peschel [12] | 2000 | 39 | - | 27% at 3 years |
Pisansky [13] | 2000 | 166 | 52 | 46% at 5 years |
Catton [14] | 2001 | 59 | 44 | 48% at 3 years |
Koppie [15] | 2001 | 67 | 36 | 44% at 3 years |
Leventis [16] | 2001 | 49 | 29 | 43% at 3 years |
Vanuytsel [17] | 2001 | 53 | 36 | 46% at 3 years |
Chawla [18] | 2002 | 54 | 45 | 35% at 5 years |
De la Taille [19] | 2002 | 52 | 28 | 51% at 3 years |
Do [20] | 2002 | 73 | 87 | 45% at 10 years |
Kalapurakal [21] | 2002 | 41 | 31 | 57% at 5 years |
Song [22] | 2002 | 61 | 36 | 39% at 4 years |
Liauw [23] | 2003 | 51 | 46 | 56% at 3 years |
Peyromaure [24] | 2003 | 62 | 44 | 42% at 5 years |
Taylor [25] | 2003 | 44 | 35 | 66% at 5 years |
Mc Donald [26] | 2004 | 102 | 50 | 38% at 5 years |
Stephenson [27] | 2004 | 501 | 45 | 50% at 45 months |
Patel [28] | 2005 | 48 | 16 | 62.5% at 16 months |
Buskirk [29] | 2006 | 368 | 60 | 46% at 5 years |
Neuhof [30] | 2007 | 171 | 39 | 35% at 5 years |
Stockdale [31] | 2007 | 32 | 30 | 56% at 30 months |
Current study | - | 59 | 38 | 56% at 3 years |